A carregar...
Enhanced nanoparticle delivery exploiting tumour-responsive formulations
Nanoparticles can be used as drug carriers, contrast agents and radiosensitisers for the treatment of cancer. Nanoparticles can either passively accumulate within tumour sites, or be conjugated with targeting ligands to actively enable tumour deposition. With respect to passive accumulation, particl...
Na minha lista:
| Publicado no: | Cancer Nanotechnol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Vienna
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6276285/ https://ncbi.nlm.nih.gov/pubmed/30595759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12645-018-0044-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|